Growth Metrics

Akebia Therapeutics (AKBA) Non-cash Items (2016 - 2018)

Akebia Therapeutics has reported Non-cash Items over the past 5 years, most recently at $3.2 million for Q4 2019.

  • Quarterly Non-cash Items rose 34.95% to $3.2 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2019, up 34.95% year-over-year, with the annual reading at $3.2 million for FY2019, 34.95% up from the prior year.
  • Non-cash Items was $3.2 million for Q4 2019 at Akebia Therapeutics, up from $2.4 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $21.9 million in Q4 2017 and troughed at $2.4 million in Q4 2018.
  • The 5-year median for Non-cash Items is $10.4 million (2016), against an average of $10.2 million.
  • Year-over-year, Non-cash Items skyrocketed 110.13% in 2017 and then crashed 89.28% in 2018.
  • A 5-year view of Non-cash Items shows it stood at $13.1 million in 2015, then dropped by 20.41% to $10.4 million in 2016, then skyrocketed by 110.13% to $21.9 million in 2017, then crashed by 89.28% to $2.4 million in 2018, then surged by 34.95% to $3.2 million in 2019.
  • Per Business Quant, the three most recent readings for AKBA's Non-cash Items are $3.2 million (Q4 2019), $2.4 million (Q4 2018), and $21.9 million (Q4 2017).